Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our list of clinical trials that are currently enrolling new pediatric patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.
| Title |
Investigator |
Disease(s) |
|---|---|---|
|
Molecular Characterization of Neuroblastic Tumors and Clinical Outcome [Protocol 00-109] |
Cheung, Nai-Kong |
|
|
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation from HLA-Compatible Unrelated Donors in Severe Aplastic Anemia [Protocol 06-056] |
Castro-Malaspina, Hugo |
|
|
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS [Protocol 08-008] |
Castro-Malaspina, Hugo |
|
|
A Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia [Protocol 08-031] |
Boulad, Farid |
|
|
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies [Protocol 06-125] |
Boulad, Farid |
|
|
A Phase I Study of Humanized 3F8 Monoclonal Antibody in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors [Protocol 11-009] |
Basu, Ellen |
|
|
Transplantation of Unrelated Donor Double-Unit Cord Blood with T-Cell-Depleted Stem Cells for Patients with High-Risk Hematologic Cancers [Protocol 12-153] |
Barker, Juliet |
|
|
Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy [Protocol 06-014] |
Barker, Juliet |
|
|
A Phase II Study of Everolimus, Leuprolide/Letrozole, and Everolimus/Leuprolide/Letrozole in Patients with Inoperable Fibrolamellar Hepatocellular Carcinoma [Protocol 11-211] |
Abou-Alfa, Ghassan |
|
